Invesco Pharmaceuticals ETFPJP
PJP
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
3% more funds holding
Funds holding: 93 [Q4 2024] → 96 (+3) [Q1 2025]
1.31% less ownership
Funds ownership: 24.13% [Q4 2024] → 22.82% (-1.31%) [Q1 2025]
8% less capital invested
Capital invested by funds: $64.9M [Q4 2024] → $59.6M (-$5.33M) [Q1 2025]
34% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 29
Research analyst outlook
We haven’t received any recent analyst ratings for PJP.
Financial journalist opinion
Neutral
Seeking Alpha
2 weeks ago
Healthcare Sector Checkup As U.S. Looks To Change Regulations
Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.
Negative
Seeking Alpha
1 month ago
PJP: The Pharma Executive Order May Be Inconsequential
President Trump's executive order on drug pricing caused a surprising rally in pharmaceutical stocks, despite initial fears of negative impacts on profit margins. The order lacks enforcement mechanisms, making it difficult to implement, which may explain the positive market reaction. Distributors like McKesson and Cardinal Health were negatively impacted, while manufacturers in the PJP ETF saw gains.
Positive
Zacks Investment Research
1 month ago
ETFs on the Move Post U.S.-China Trade Deal
Let's delve into the ETF world following the 90-day U.S.-China trade deal.
Neutral
Zacks Investment Research
1 month ago
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
Launched on 06/23/2005, the Invesco Pharmaceuticals ETF (PJP) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market.
Positive
Zacks Investment Research
1 month ago
A Look at Pharma ETFs After Strong Q1 Earnings
Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.
Neutral
Zacks Investment Research
1 month ago
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Launched on 06/23/2005, the Invesco Pharmaceuticals ETF (PJP) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of the equity market.
Negative
Market Watch
2 months ago
Trump teases targeted tariffs on overseas drug manufacturers
With the next set of White House–imposed tariffs just hours away from taking effect — including the attention-hogging 104% rate to be levied on products from China as they're imported into the U.S. — President Donald Trump indicated he intends to roll out more product-specific tariffs down the road.
Neutral
Zacks Investment Research
3 months ago
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
The Invesco Pharmaceuticals ETF (PJP) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Neutral
Seeking Alpha
3 months ago
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?
Neutral
Zacks Investment Research
4 months ago
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the Invesco Pharmaceuticals ETF (PJP), a passively managed exchange traded fund launched on 06/23/2005.
Charts implemented using Lightweight Charts™